Detalhe da pesquisa
1.
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
PLoS One;
16(11): e0260066, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34793550
2.
[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
J Clin Oncol;
34(16): 1889-97, 2016 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27001573